Intravenous misuse of buprenorphine: Characteristics and extent among patients undergoing drug maintenance therapy

Clinical Drug Investigation

Volumn 30, Issue SUPPL. 1, 2010, Pages 3-11

  Moratti, Enrico ^a   Kashanpour, Hamid ^a   Lombardelli, Tiziana ^a   Maisto, Maria ^a  

^a Drug Addiction Centre   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; ARTICLE; DRUG MISUSE; FEMALE; GROUPS BY AGE; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ABUSE; ITALY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MOTIVATION; OPIATE ADDICTION; PATIENT ATTITUDE; PERCEPTION; PERSONAL EXPERIENCE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; WITHDRAWAL SYNDROME; ADDICTION; AGE; COMPARATIVE STUDY; DRUG DEPENDENCE TREATMENT; HEALTH CARE SURVEY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; OPIOID-RELATED DISORDERS; PSYCHOLOGY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SUBLINGUAL DRUG ADMINISTRATION; SUBSTANCE ABUSE; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; AGE FACTORS; ANALGESICS, OPIOID; BEHAVIOR, ADDICTIVE; BUPRENORPHINE; FEMALE; HEALTH CARE SURVEYS; HUMANS; INJECTIONS, INTRAVENOUS; ITALY; MALE; METHADONE; MIDDLE AGED; MOTIVATION; OPIOID-RELATED DISORDERS; PERCEPTION; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 77952356753     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11536020-000000000-00000     Document Type: Article

References (29)

1. Johnson RE, Chutuape MA, Strain EC, et al. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.NEngl J Med 2000Nov 2; 343 (18): 1290-1297.
2. O'Connor PG, Oliveto AH, Shi JM, et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med 1998 Aug; 105 (2): 100-105.
3. Strain EC, Stitzer ML, Liebson IA, et al. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index. J Clin Psychopharmacol 1996 Feb; 16 (1): 58-67.
4. Martin WR, Eades CG, Thompson JA, et al. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976 Jun; 197 (3): 517-532.
5. Milne M, Crouch BI, Caravati EM. Buprenorphine for opioid dependence. J Pain Palliat Care Pharmacother 2009; 23 (2): 153-155.
6. Umbricht A, Huestis MA, Cone EJ, et al. Effects of highdose intravenous buprenorphine in experienced opioid abusers. J Clin Psychopharmacol 2004 Oct; 24 (5): 479-487.
7. Roux P, Villes V, Blanche J, et al. Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management. Drug Alcohol Depend 2008 Sep 1; 97 (1-2): 105-113.
8. Guichard A, Lert F, Calderon C, et al. Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France. Addiction 2003 Nov; 98 (11): 1585-1597.
9. Jenkinson RA, Clark NC, Fry CL, et al. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? Addiction 2005 Feb; 100 (2): 197-205.
10. Anonymous. Drug injectors in Glasgow: a community at risk? A report from a multidisciplinary group. The Possilpark Group. Health Bull (Edinb) 1993 Nov; 51 (6): 418-429.
11. Robinson GM, Dukes PD, Robinson BJ, et al. The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand. Drug Alcohol Depend 1993 Jun; 33 (1): 81-86.
12. European Monitoring Centre for Drugs and Drug Addiction. Annual report: the state of the drugs problemin Europe. 2007.
13. European Monitoring Centre for Drugs and Drug Addiction. Annual report: the state of the drugs problemin Europe. 2005.
14. Obadia Y, Perrin V, Feroni I, et al. Injecting misuse of buprenorphine among French drug users. Addiction 2001 Feb; 96 (2): 267-272.
15. Barrau K, Thirion X, Micallef J, et al. Comparison of methadone and high dosage buprenorphine users in French care centres. Addiction 2001 Oct; 96 (10): 1433-1441.
16. Varescon I, Vidal-Trecan G, Nabet N, et al. Buprenorphine abuse: high dose intravenous administration of buprenorphine. Encephale 2002 Sep-Oct; 28 (5 Pt 1): 397-402.
17. Vidal-Trecan G, Varescon I, Nabet N, et al. Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France. Drug Alcohol Depend 2003 Mar 1; 69 (2): 175-181.
18. Blanchon T, Boissonnas A, Vareseon I, et al. Homelessness and high-dosage buprenorphine misuse. Subst Use Misuse 2003 Feb-May; 38 (3-6): 429-442.
19. Auriacombe M, Fatseas M, Dubernet J, et al. French field experience with buprenorphine. Am J Addict 2004; 13 Suppl. 1: S17-28.
20. Alho H, Sinclair D, Vuori E, et al. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. Drug Alcohol Depend 2007 Apr 17; 88 (1): 75-78.
21. Hakansson A, Medvedeo A, Andersson M, et al. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration. Eur Addict Res 2007; 13 (4): 207-215.
22. Aitken CK, Higgs PG, Hellard ME. Buprenorphine injection in Melbourne, Australia-an update. Drug Alcohol Rev 2008 Mar; 27 (2): 197-199.
23. Cicero TJ, Inciardi JA. Potential for abuse of buprenorphine in office-based treatment of opioid dependence. N Engl J Med 2005 Oct 27; 353 (17): 1863-1865.
24. Sakol MS, Stark C, Sykes R. Buprenorphine and temazepam abuse by drug takers in Glasgow-an increase. Br J Addict 1989 Apr; 84 (4): 439-441.
25. Fudala PJ, Yu E, Macfadden W, et al. Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts. Drug Alcohol Depend 1998 Mar 1; 50 (1): 1-8.
26. Mendelson J, Jones RT. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment? Drug Alcohol Depend 2003 May 21; 70 (2 Suppl.): S29-37.
27. Mendelson J, Jones RT, Welm S, et al. Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers. Psychopharmacology (Berl) 1999 Jan; 141 (1): 37-46.
28. Comer SD, Walker EA, Collins ED. Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers. Psychopharmacology (Berl) 2005 Oct; 181 (4): 664-675.
29. Degenhardt L, Larance BK, Bell JR, et al. Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation. Med J Aust 2009 Aug 3; 191 (3): 161-165.